Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer.

Joe AK, Arber N, Bose S, Heitjan D, Zhang Y, Weinstein IB, Hibshoosh H.

Anticancer Res. 2001 Sep-Oct;21(5):3535-9.

PMID:
11848520
2.

Cyclin D1 overexpression is associated with estrogen receptor expression in Caucasian but not African-American breast cancer.

Joe AK, Memeo L, Mckoy J, Mansukhani M, Liu H, Avila-Bront A, Romero J, Li H, Troxel A, Hibshoosh H.

Anticancer Res. 2005 Jan-Feb;25(1A):273-81.

3.

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.

Hui R, Ball JR, Macmillan RD, Kenny FS, Prall OW, Campbell DH, Cornish AL, McClelland RA, Daly RJ, Forbes JF, Blamey RW, Musgrove EA, Robertson JF, Nicholson RI, Sutherland RL.

Oncogene. 1998 Aug 27;17(8):1053-9.

4.

Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women.

Terry MB, Gammon MD, Schoenberg JB, Brinton LA, Arber N, Hibshoosh H.

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1100-3.

5.

Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients.

Hwang TS, Han HS, Hong YC, Lee HJ, Paik NS.

Pathol Int. 2003 Feb;53(2):74-80.

PMID:
12588434
6.

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.

Reis-Filho JS, Savage K, Lambros MB, James M, Steele D, Jones RL, Dowsett M.

Mod Pathol. 2006 Jul;19(7):999-1009. Epub 2006 Apr 28.

8.

Cyclin D1 protein overexpression and gene amplification in benign breast tissue and breast cancer risk.

Kandel R, Zhu XL, Li SQ, Rohan T.

Eur J Cancer Prev. 2001 Feb;10(1):43-51.

PMID:
11263590
9.

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.

Elsheikh S, Green AR, Aleskandarany MA, Grainge M, Paish CE, Lambros MB, Reis-Filho JS, Ellis IO.

Breast Cancer Res Treat. 2008 May;109(2):325-35. Epub 2007 Jul 26.

PMID:
17653856
10.

Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.

Pacilio C, Germano D, Addeo R, Altucci L, Petrizzi VB, Cancemi M, Cicatiello L, Salzano S, Lallemand F, Michalides RJ, Bresciani F, Weisz A.

Cancer Res. 1998 Mar 1;58(5):871-6.

11.

Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.

Kawakubo H, Brachtel E, Hayashida T, Yeo G, Kish J, Muzikansky A, Walden PD, Maheswaran S.

Cancer Res. 2006 Jul 15;66(14):7075-82.

12.

[Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].

Yang JF, Chen SL, Liu ZH, Zhang Y.

Ai Zheng. 2004 Jul;23(7):799-802. Chinese.

PMID:
15248915
13.

Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.

Lim SC.

Oncol Rep. 2003 Sep-Oct;10(5):1241-9.

PMID:
12883688
14.

[Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer].

Song YC, Fu SD, Wen XP, Ma ZH, Dang CX.

Ai Zheng. 2007 Jul;26(7):709-14. Chinese.

PMID:
17626745
15.

Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.

Lim SC, Lee MS.

Oncol Rep. 2002 Sep-Oct;9(5):915-28.

PMID:
12168049
16.

Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.

Aaltonen K, Amini RM, Landberg G, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H, Blomqvist C.

Breast Cancer Res Treat. 2009 Jan;113(1):75-82. doi: 10.1007/s10549-008-9908-5. Epub 2008 Feb 1.

PMID:
18240019
17.

Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.

Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H.

Clin Cancer Res. 2008 Apr 1;14(7):1976-83. doi: 10.1158/1078-0432.CCR-07-4100.

18.
19.

Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.

Guo LL, Gao P, Wu YG, Jian WC, Hao CY, Li H, Lin XY.

Arch Med Res. 2007 Nov;38(8):846-52. Epub 2007 Aug 2.

PMID:
17923265
20.

Supplemental Content

Support Center